BACKGROUND: Detection of the earliest cognitive changes signifying Alzheimer disease is difficult. OBJECTIVE: To model the cognitive decline in preclinical Alzheimer disease. DESIGN: Longitudinal archival study comparing individuals who became demented during follow-up and people who remained nondemented on each of 4 cognitive factors: global, verbal memory, visuospatial, and working memory. SETTING: Alzheimer Disease Research Center, Washington University School of Medicine, St Louis, Missouri. PARTICIPANTS: One hundred thirty-four individuals who became demented during follow-up and 310 who remained nondemented. MAIN OUTCOME MEASURES: Inflection point in longitudinal cognitive performance. RESULTS: The best-fitting model for each o...
We examined the pattern of cognitive impairment and rate of cognitive and functional decline as a fu...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
Copyright © INS. Published by Cambridge University Press, 2020.Objective: Alzheimer's disease (AD) s...
Background: Alzheimer’s disease (AD) is now understood to have a long preclinical phase in which pat...
Objective: To investigate the temporal ordering of cognitive and functional declines separately in o...
BACKGROUND: The characterizing symptom of Alzheimer disease (AD) is cognitive deterioration. While m...
BACKGROUND: Understanding the earliest manifestations of Alzheimer's disease (AD) is key to realisin...
Objective: Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarker...
Individuals with Alzheimer Disease (AD) exhibit deficits across multiple cognitive domains years bef...
Objective: This study measured the annual rate ofcognitive change in patients with Alzhei-mer’s dise...
Objective: To assess whether neurodegenerative pathologies are differentially related to trajectorie...
BACKGROUND: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
BACKGROUND/OBJECTIVES: Longitudinal studies have shown an increase in cognitive decline many years b...
We attempted to characterize the changes in cognition associated with the earliest, or preclinical, ...
Background: Community- or population-based longitudinal studies of cognitive ability with a brain do...
We examined the pattern of cognitive impairment and rate of cognitive and functional decline as a fu...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
Copyright © INS. Published by Cambridge University Press, 2020.Objective: Alzheimer's disease (AD) s...
Background: Alzheimer’s disease (AD) is now understood to have a long preclinical phase in which pat...
Objective: To investigate the temporal ordering of cognitive and functional declines separately in o...
BACKGROUND: The characterizing symptom of Alzheimer disease (AD) is cognitive deterioration. While m...
BACKGROUND: Understanding the earliest manifestations of Alzheimer's disease (AD) is key to realisin...
Objective: Several models have been proposed for the evolution of Alzheimer’s disease (AD) biomarker...
Individuals with Alzheimer Disease (AD) exhibit deficits across multiple cognitive domains years bef...
Objective: This study measured the annual rate ofcognitive change in patients with Alzhei-mer’s dise...
Objective: To assess whether neurodegenerative pathologies are differentially related to trajectorie...
BACKGROUND: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
BACKGROUND/OBJECTIVES: Longitudinal studies have shown an increase in cognitive decline many years b...
We attempted to characterize the changes in cognition associated with the earliest, or preclinical, ...
Background: Community- or population-based longitudinal studies of cognitive ability with a brain do...
We examined the pattern of cognitive impairment and rate of cognitive and functional decline as a fu...
Objective: Alzheimer's disease (AD) studies are increasingly targeting earlier (pre)clinical populat...
Copyright © INS. Published by Cambridge University Press, 2020.Objective: Alzheimer's disease (AD) s...